{
    "title": "Novartis ' spending on research and development by segment 2017 to 2019",
    "labels": [
        "Company",
        "2017",
        "2018",
        "2019"
    ],
    "columnType": "multi",
    "graphType": "bar",
    "summary": [
        "This statistic shows the Novartis ' spending research of development in Novartis 2017 and 2019 . ",
        "In the first Company of 2019 , the ' spending research of development in Novartis the country was 7.62 U.S. dollars . ",
        "In 2017 , there were 5.6 million international overnight visitors to Novartis ."
    ],
    "trends": [
        {},
        {},
        {}
    ],
    "data": [
        {
            "Company": "Innovative Medicines",
            "2017": "7.62",
            "2018": "7.68",
            "2019": "8.15"
        },
        {
            "Company": "Sandoz",
            "2017": "0.77",
            "2018": "0.81",
            "2019": "1.25"
        },
        {
            "Company": "Alcon",
            "2017": "0.58",
            "2018": "0.59",
            "2019": "0"
        }
    ],
    "gold": [
        "This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2019 , by business segment. ",
        "In 2016 and 2017 , in both years , the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division ."
    ]
}